Share this to:

Support & Insight for the Autumn of Life

Discovery of Biomarker Could Predict Alzheimer’s in Blood Test

A certain protein in the blood can be used to predict the eventual appearance of Alzheimer's. Will this allow for early intervention?

A unique brain protein measured in the blood could be used to diagnose Alzheimer’s disease decades before symptoms develop, according to research by a team at Edith Cowan University (ECU) in Western Australia.

Published in Nature’s journal of Translational Psychiatry, the study is the first to find that people with elevated glial fibrillary acidic protein (GFAP) in the blood also have increased amyloid beta in the brain, a known indicator of Alzheimer’s disease.

GFAP is a protein normally found in the brain, but it is released into the blood when the brain is damaged by early Alzheimer’s disease.

Alzheimer’s disease affects more than 340,000 Australians and more than 35 million people in the world. Current diagnosis involves a brain scan or spinal fluid tests.

The study’s lead researcher, ECU Professor Ralph Martins AO, said the discovery offered a promising new avenue for early diagnosis.

“Blood biomarkers are becoming an exciting alternative to the existing expensive and invasive methods of diagnosing Alzheimer’s disease,” said Professor Martins.

“The GFAP biomarker could be used to develop a simple and quick blood test to detect if a person is at very high risk of developing Alzheimer’s.

“Early diagnosis is critical to allow us to implement medication and lifestyle interventions that can help delay the progression of the disease and give people more time before symptoms develop.”

A step forward

Alzheimer’s disease is a degenerative brain condition that can develop silently over years. It leads to memory decline and loss of thinking skills. There is no known cure.

According to Professor Martins, the development of an early blood test for the disease will be revolutionary.

“The technology for detecting biomarkers has developed rapidly, so I think we will begin to see diagnostic blood tests being used for Alzheimer’s in the next few years.

“The current brain imaging and lumbar puncture tests are expensive and invasive and not widely available to the general population. A blood test could open up possibilities for early diagnosis of millions of people and thereby enable earlier interventions.”

Future hope

The study involved 100 Australians aged between 65 and 90 years of age with no symptoms of Alzheimer’s disease.

Professor Martins said further research is needed to understand GFAP in Alzheimer’s disease.

“Longitudinal studies will provide more insight into how GFAP relates to the progression of Alzheimer’s, which may allow us to determine when symptoms will emerge.”

Professor Martins is also part of a large study exploring interventions for Alzheimer’s disease, with the ultimate goal of finding medications and lifestyle factors that can halt or delay the development of the disease.

“Diagnosis and intervention techniques go hand in hand – if we can use blood biomarkers to detect Alzheimer’s sooner, we can also intervene sooner,” he said.

The study was a collaboration with Dr Pratishtha Chatterjee from Macquarie University, who is the first author on the paper.

Professor Martins is the director of the Centre of Excellence for Alzheimer’s Disease Research and Care and also leads the Western Australian site of the Dominantly Inherited Alzheimer’s Network (DIAN) – a global longitudinal study of people with genetically inherited Alzheimer’s disease.

‘Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease’ was published in Translational Psychiatry.



  • Chatterjee, P., Pedrini, S., Stoops, E. et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s diseaseTransl Psychiatry 11, 27 (2021). DOI: 10.1038/s41398-020-01137-1
Notify of

Inline Feedbacks
View all comments
February 28, 2021 8:03 pm

Would it be possible to have this blood test if you think yo I have early onset dementia?

Julia M. Nusrallah
Julia M. Nusrallah
March 2, 2021 4:01 am

When and where will the test be available?

B. Berger

B. Berger

Visit Our Pages On:


This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor


Cataract Surgery Linked to Less Dementia Risk
Researchers in Seattle, Washington have discovered that cataract surgery is associated with a lower risk of developin...
The Missing Link Between Alzheimer's & Vascular Disease
Researchers in New York found a gene that links cerebrovascular disease and Alzheimer’s.
NanoDevices Trap Dangerous Alzheimer's Plaque
Nanodevices are the newest weapon in medicine’s growing arsenal to fight Alzheimer’s. They capture dangerous peptides...


Amazon Books
Would love your thoughts, please comment.x
News to Get at the Truth

Subscribe To Our Weekly Newsletter

Enjoy thought-provoking videos & articles
News to Get at the Truth

Subscribe To Our Weekly Newsletter